General Information
BounceWatch is an independent company data service, not affiliated with Epic Sciences. To contact Epic Sciences, visit epicsciences.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Epic Sciences
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series G | $24.00M | 5 | 14 Apr 2023 | |
| Series F | $43.00M | 4 | 01 Jun 2022 | |
| Series E | $52.00M | 9 | 12 Sep 2018 | |
| Series D | $40.00M | 9 | 28 Apr 2017 | |
| Debt Financing | $15.00M | 1 |
Silicon Valley Bank
|
01 Jun 2015 |
| Series C | $30.00M | 5 | 30 Jul 2014 | |
| Series B | $13.00M | 3 | 13 Nov 2012 | |
| Series A | $2.50M | 1 | 30 Jun 2009 |
Epic Sciences Alternatives & Competitors
Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis
Pioneering the future of cancer diagnostics through advanced epigenetic testing and innovative histo...
Freeing patients from the tyranny of cancer™
FAQ About Epic Sciences
Source: BounceWatch company record for Epic Sciences, https://bouncewatch.com/company/epic-sciences, updated 25 November 2024. When citing, please name BounceWatch and link this page.